EN DE

Azelis Group (AZE) Fair Value & Analysis

Basic Materials · BE · Market cap €2.8B

AG Azelis Group AZE · BR
Price€11.78
Fair Value€8.27
Upside-29.8%
Quality54/100
Watch Azelis Group for free, get notified when fair value or trend changes. Watch for free
Mixed Growth
Thin margins · 2.7% net margin
Moderate debt · generates free cash flow
1.96% dividend yield
Mixed vs. peers (7/14)
Narrow moat 30/100
Evidence: High Range €7.43 – €9.71 Share as image

Fair value as of: Aug 6, 2026

From 26 valuation models · updated 6 days ago

Fair value updated Aug 6, 2026, revised from €8.54 to €8.27 (−3.2%) since Jul 14, 2026. Share price +15.0% over the past month.

A solid business, but screening 30% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (€9.71). The favourable scenario is already priced in.
  • Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

€26.52 €6.79 Fair Value €8.27 Sep 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 6, 2026.

How to read this chart

59‑month range €6.79 – €26.52 · fair‑value band €7.43 – €9.71 · the €11.78 price screens above the €8.27 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 6, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Azelis Group (AZE) currently trades at €11.78, while our model-based Fair Value estimate is €8.27, implying the stock looks roughly 29.8% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, Azelis Group generated revenue of €4.1B at a net margin of 2.7%. Revenue declined 5.6% year over year. It earns a return on equity of 4.0%. Net debt stands at €1.7B. Fundamentals as of Aug 6, 2026

Our scenario range runs from €7.43 (bear case) to €9.71 (bull case); at €11.78, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 22% below its 52-week high and 71% above its 52-week low, currently above its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at -58% fair-value upside, at -30%, AZE screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF €10.48 €26.06 €53.25 80
Residual Income €8.19 €8.13 €7.30 76
Rev-Margin DCF €7.35 €18.28 €34.03 74
All 26 models by family
DCF Models
FCF DCF €11.11 €23.28 €54.73 38
Owner Earnings €6.89 €20.45 €46.61 31
5Y Revenue Exit €7.35 €18.23 €35.19 39
5Y EBITDA Exit €8.17 €20.05 €37.35 41
5Y P/E Exit €3.43 €9.80 €17.42 38
10Y Revenue Exit €8.03 €19.75 €37.01 36
10Y EBITDA Exit €9.00 €21.18 €41.92 37
10Y P/E Exit €5.79 €12.93 €23.82 35
Earnings-Based
Graham-Dodd €3.11 €19.83 €27.71 54
Lynch FV €5.74 €8.20 €10.66 50
PEG = 1.0 €5.74 €8.20 €10.66 46
EPV €3.08 €4.44 €5.60 59
Dividend Discount
Gordon GGM €1.98 €3.95 €5.98 70
DDM Multi-Stage €1.98 €3.41 €4.17 61
Multiples
P/E Multiple €5.83 €7.77 €9.71 63
P/S Multiple €5.83 €7.77 €9.71 58
P/B Multiple €5.83 €7.77 €9.71 55
EV/EBIT €7.08 €11.27 €15.47 53
EV/EBITDA €7.40 €11.71 €16.01 54
EV/Revenue €5.40 €10.07 €14.75 43
Asset-Based
NCAV (Graham) €5.54 €7.42 €11.07 50
Growth DCF
Growth DCF €10.48 €26.06 €53.25 80
Rev-Margin DCF €7.35 €18.28 €34.03 74
Economic Profit
Residual Income €8.19 €8.13 €7.30 76
ROIC Compounder €3.08 €4.44 €5.60 72
Growth Earnings
Growth-Adj P/E €7.43 €10.61 €13.80 68

Widest divergence: DCF Models (€19.75) versus Dividend Discount (€3.41). Highest evidence: Growth DCF (80).

Notify me when AZE reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) €4.1B
Revenue growth (YoY) -5.6%
Net margin 2.7%
Return on equity 4.0%
Free cash flow €286M FY2025
P/E ratio 22.7
More key figures
Operating margin 6.9%
EPS (TTM) €0.4600
Dividend yield 2.2%
EPS growth (YoY) -67.6%
Net debt €1.7B FY2025

Figures from reported company fundamentals · as of Aug 6, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 54/100

Of which business quality 54 · Market factors (momentum, volatility) 56

Profitability 29
Margins and returns on capital today
Quality Growth 30
Are margins and returns improving?
Cashflow 68
Earnings quality: real cash, not paper profit
Fin. Strength 44
Balance sheet, leverage, solvency risk
Investment 88
Disciplined investing over empire-building
Low Volatility 73
Calm price path (market factor)
Momentum 48
Price trend over the last 3–12 months (market factor)
52W Momentum 51
Distance to the 52-week high (market factor)
Net Issuance 80
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals …

Full company description

Azelis Group NV engages in the distribution of specialty chemicals and food ingredients. The company provides specialty chemical products used in the life sciences, such as personal care, home care, industrial cleaning, pharmaceuticals, healthcare, food and nutrition, animal nutrition, agricultural environmental, flavours and fragrances, and nutraceuticals solutions; and industrial chemicals industry, including CASE, advanced materials and additives, lubricants, metalworking fluids, electronics, essential and fine chemicals, textiles, leather, and paper markets. It operates in Europe, Middle East, and Africa, as well as the Americas and the Asia-Pacific. Azelis Group NV was founded in 1996 and is headquartered in Antwerp, Belgium.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Azelis Group reported revenue of €4.1B in FY2025 versus €2.8B in FY2021, a compound +9.8%/yr. Reported net income was €111M in FY2025, compounding +13.2%/yr from FY2021.

Growth Quality 74/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
€4.1B
Latest YoY
−3.0%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−0.1%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+11.9%
Avg. growth/yr (7Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+48.6%
Revenue +9.8%/yr
FY21 €2.8B
FY22 €4.1B
FY23 €4.2B
FY24 €4.2B
FY25 €4.1B
Net income +13.2%/yr
FY21 €67.8M
FY22 €213M
FY23 €178M
FY24 €181M
FY25 €111M

AZE screens 30% overvalued. Compare with Linde plc →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Azelis Group Fair Value". https://www.fairvalue-calculator.com/stock/AZE

Peer Group

Specialty Chemicals · 670 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 54 · Above median
Fair Value upside −30% · Below median
Return on equity (TTM) 4% · Below median
Return on assets 4% · Above median
Net margin (TTM) 3% · Below median
Operating margin (TTM) 9% · Above median
Revenue growth 0% · Below median
Dividend yield (TTM) 2.0% · Above median
Debt / equity 0.60× · Higher than 75% of peers

Valuation Multiples vs Specialty Chemicals median · lower = cheaper

P/E (TTM) 24.7× · Cheaper than median
P/B 1.21× · Cheaper than median
P/S (TTM) 0.79× · Cheaper than median
P/FCF 11.4× · Pricier than 75% of peers
EV/EBITDA 11.4× · Pricier than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 2 · sector 20
PAST 16 · sector 23
HEALTH 70 · sector 95
DIVIDEND 39 · sector 25

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 6, 2026).

Stock Price Fair Value vs Fair Value
Linde plc LIN $489.98 $222.03 -55%
Nan Ya Plastics Corporation 1303 181.50 TWD 255.83 TWD +41%
Wanhua Chemical Group 600309 ¥70.04 ¥68.03 -3%
Novozymes A/S NSISB kr 428.20 kr 179.66 -58%
Asian Paints Limited ASIANPAINT ₹2,689 ₹668.81 -75%
Solar Industries India Limited SOLARINDS ₹18,236 ₹2,793 -85%
Pidilite Industries Limited PIDILITIND ₹1,560 ₹351.84 -77%
PT Chandra Asri Pacific Tbk TPIA 1,805 IDR 2,888 IDR +60%
Linde India Limited LINDEINDIA ₹7,115 ₹757.93 -89%
Berger Paints India Limited BERGEPAINT ₹493.70 ₹164.29 -67%

Compare Azelis Group with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Azelis Group (AZE) overvalued or undervalued?
As of Aug 6, 2026, our model estimates a fair value of €8.27 versus a price of €11.78, about −30% (overvalued).
What is the fair value of AZE?
Our model-based fair value for Azelis Group is €8.27 (as of Aug 6, 2026), built from audited fundamentals. The current price is €11.78.
What is the quality score of AZE?
Azelis Group has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Azelis Group (AZE)?
Azelis Group reported trailing-twelve-month revenue of about €4.1B (latest available figure, as of Aug 6, 2026).
What is the net profit margin of AZE?
The net profit margin of Azelis Group is about 2.7%, meaning it keeps roughly 2.7% of revenue as net income. Based on the latest reported figures.
Does Azelis Group pay a dividend?
Azelis Group currently shows a dividend yield of about 2.20% relative to its recent price (as of Aug 6, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Azelis Group and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.